Tag: may

Use of ibuprofen and similar NSAIDs may shorten life of patients

Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs’ promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study in the journal Kidney Cancer indicated that non-aspirin

People with false-positive cancer screening results may be more likely to receive future screening

An analysis of electronic medical records indicates that patients who previously had a false-positive breast or prostate cancer screening test are more likely to obtain future recommended cancer screenings. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings suggest that false-positives may be reminders to screen for cancer. Additional

Drinking water may help exercising seniors stay mentally sharp

Older people should drink more water to reap the full cognitive benefits of exercise, new research suggests. The study, to be presented today at the American Physiological Society (APS) annual meeting at Experimental Biology 2018 in San Diego, explores the association between hydration status before exercising and exercise-enhanced cognition in older adults. Dehydration has been

Aspirin may reduce cardiovascular risk during bereavement

An investigation that has appeared in the current issue of Psychotherapy and Psychosomatics suggests that low-dose aspirin may have a role in the prevention of cardiovascular risk associated with bereavement. In the 24 h following the death of a significant person, the incidence of acute myocardial infarction increases 21.1-fold. Low-dose aspirin could be a suitable

Targeting enzyme may tip cancer ‘over the edge’

Researchers from the University of Dundee have identified an enzyme critical for cell division that could potentially be targeted to tip tumours ‘over the edge’ into remission. A team led by Professor Paul Clarke and Dr. Adrian Saurin, from the University’s School of Medicine, discovered that the enzyme USP9X controls the proper timing of cell

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like

Overeating? It may be a brain glitch

With springtime comes the desire to shed those few extra pounds, in preparation to don swimsuits and head to the pool. This year, new obesity research is making it easier to find a pathway that is right for us. There is no doubt that weight loss is a higher priority than ever before. Americans have

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in

Video games may be OK for toddlers—if mom or dad join in

(HealthDay)—Parents, you may be able to stop feeling guilty about letting your toddlers play video games—as long as you’re playing with them. That’s the suggestion of a small study on the effects of touchscreen technology on kids’ development. The research dovetails with growing concern that toddlers might be harmed as technology takes center stage in